Susquehanna International Group, LLP Aurinia Pharmaceuticals Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 181,783 shares of AUPH stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,783
Previous 163,073
11.47%
Holding current value
$2.1 Million
Previous $1.31 Million
17.39%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding AUPH
# of Institutions
245Shares Held
62.5MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$116 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$107 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$45.9 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$32.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.7 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.64B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...